A highly reliable partner for GMP radiopharmaceuticals
Global Morpho Pharma SAS is a French company created early 2018 that aims at developing, distributing and selling radionuclides and radiopharmaceuticals under Good Manufacturing Practice (GMP) quality for the benefit of the patients and the expanding nuclear medicine industry. Global Morpho Pharma intends to become one of the major suppliers of pharmaceutical grade doses of radiolabeled compounds for the pharmaceutical industry. The abbreviated name of the company, GMP stands as well as for Good Manufacturing Practices and points clearly to its major aims: Quality, Reliability, Sustainability.
Global Morpho Pharma is presently building a network of centers covering the entire supply chain, from the original target to the pharmaceutical grade radionuclide for human use, eventually to the final ready-to-use drug. This network includes for each step backup solutions in both the US and EU to avoid rupture of supply in case of maintenance or temporary shutdowns.
Come and visit us at booth 565